Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
Author(s) -
HsinYun Sun,
Barbara D. Alexander,
Olivier Lortholary,
Françoise Dromer,
Graeme N. Forrest,
G. Marshall Lyon,
Jyoti Somani,
Krishan Lal Gupta,
Ramon Del Busto,
Timothy L. Pruett,
Costi D. Sifri,
Ajit P. Limaye,
George John,
Göran B. Klintmalm,
Kenneth Pursell,
Valentina Stosor,
Michelle I. Morris,
Lorraine A. Dowdy,
Patricia Muñóz,
André C. Kalil,
Julia GarciaDiaz,
Susan L. Orloff,
Andrew A. House,
Sally Houston,
Dannah Wray,
Shirish Huprikar,
Leonard B. Johnson,
Atul Humar,
Raymund R. Razonable,
Shahid Husain,
Nina Singh
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/647948
Subject(s) - amphotericin b , medicine , fungemia , amphotericin b deoxycholate , odds ratio , gastroenterology , univariate analysis , antifungal drug , cryptococcosis , confidence interval , surgery , mycosis , immunology , antifungal , multivariate analysis , caspofungin , dermatology
Whether outcome of central nervous system (CNS) cryptococcosis in solid organ transplant recipients treated with lipid formulations of amphotericin B is different from the outcome of the condition treated with amphotericin B deoxycholate (AmBd) is not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom